Compare EHang Holdings Ltd - ADR (EH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Johnson & Johnson — how do they compare? EHang Holdings Ltd - ADR trades at $5.79 (market cap $437.63M), while Johnson & Johnson trades at $260.51 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 1430.6× EHang Holdings Ltd - ADR's market cap, and Johnson & Johnson pays a 2.06% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| EH | JNJ | |
|---|---|---|
Market Cap | $437.63M | $626.09B |
Sector | Industrials | Health |
52-Week High | $19.44 | $267.24 |
52-Week Low | $4.90 | $172.78 |
Enterprise Value | $376.84M | $654.37B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.70, up 0.18% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported Q1 2026 revenue of $418 million, with a net loss of $276 million, reflecting ongoing profitability challenges despite a high gross margin of 61.53%. Recent news includes the successful pilotless eVTOL flight in Kazakhstan, highlighting operational progress amid a volatile year for air taxi stocks.
The outlook remains speculative, with significant growth potential in the advanced air mobility market offset by persistent losses and competitive pressures. Risks include execution hurdles and funding needs, while analyst sentiment is divided with a consensus price target of $6.97 suggesting modest upside from current levels.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
